Challenge Tests of Monoaminergic Systems: Neurophysiological Aspects

Clinical EEG and Neuroscience

Volumn 38, Issue 2, 2007, Pages 66-73

  Norra, Christine ^a  

^a MAX PLANCK INSTITUTE OF EXPERIMENTAL MEDICINE   (Germany)

Author keywords

Auditory Evoked Potentials; Challenge Study; Electroencephalography; Monoamine Depletion; Polysomnography; Serotonin; Startle Response

Indexed keywords

BIOLOGICAL MARKER; DOPAMINE; METIROSINE; MONOAMINE; NEUROTRANSMITTER; NORADRENALIN; PHENYLALANINE; SEROTONIN; TRYPTOPHAN; TYROSINE;

CONFERENCE PAPER; ELECTROENCEPHALOGRAPHY; EVOKED AUDITORY RESPONSE; HUMAN; MAGNETOENCEPHALOGRAPHY; MONOAMINERGIC SYSTEM; NEUROPHYSIOLOGY; NONHUMAN; POLYSOMNOGRAPHY; PRIORITY JOURNAL; RELIABILITY; SEROTONIN BRAIN LEVEL; STARTLE REFLEX;

BIOGENIC MONOAMINES; BRAIN; BRAIN DISEASES; CLINICAL TRIALS; ELECTROENCEPHALOGRAPHY; HUMANS; MODELS, NEUROLOGICAL; NEUROPHYSIOLOGY; NEUROTRANSMITTER AGENTS; POLYSOMNOGRAPHY; SYNAPTIC TRANSMISSION;

EID: 34249880399     PISSN: 15500594     EISSN: None     Source Type: Journal    
DOI: 10.1177/155005940703800207     Document Type: Article

References (88)

1. Van Praag HM Asnis GM Kahn RS Brown SL Korn M Friedman JM Wetzler S. Nosological tunnel vision in biological psychiatry: A plea for a functional psychopathology. Ann NY Acad Sci 1990; 600: 501-510.
2. Booij L Van der Does AJ Riedel WJ. Monoamine depletion in psychiatric and healthy populations: Review. Mol Psychiatry 2003; 8: 951-973.
3. Biggio G Fadda F Fanni P Tagliamonte A Gessa GL. Rapid depletion of serum tryptophan, brain tryptophan, serotonin and 5-hydroxyindoleacetic acid by a tryptophan-free diet. Life Sci 1974; 14: 1321-1329.
4. Delgado PL Charney DS Price LH Aghajanian GK Landis H Heninger GR. Serotonin function and the mechanism of antidepressant action: Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. Arch Gen Psychiatry 1990; 47: 411-418.
5. Young SN Ervin FR Pihl RO Finn P. Biochemical aspects of tryptophan depletion in primates. Psychopharmacology 1989; 98: 508-511.
6. Benkelfat C Ellenbogen MA Dean P Palmour RM Young SN. Mood-lowering effect of tryptophan depletion: Enhanced susceptibility in young men at genetic risk for major affective disorders. Arch Gen Psychiatry 1994; 51: 687-697.
7. Carpenter LL Anderson GM Pelton GH Gudin JA Kirwin PD Price LH, et al. Tryptophan depletion during continuous CSF sampling in healthy human subjects. Neuropsychopharmacology 1998; 19: 26-35.
8. Baumann MH Ayestas MA Rothman RB. Functional consequences of central serotonin depletion produced by repeated fenfluramine administration in rats. J Neurosci 1998; 18: 9069-9077.
9. Bremner JD Innis RB Salomon RM Staib LH Ng CK Miller HL, et al. Positron emission tomography measurement of cerebral metabolic correlates of tryptophan depletion-induced depressive relapse. Arch Gen Psychiatry 1997; 54: 364-374.
10. Nishizawa S Benkelfat C Young SN Leyton M Mzengeza S De Montigny C, et al. Differences between males and females in rates of serotonin synthesis in human brain. Proc Nat Acad Sci USA 1997; 94: 5308-5313.
11. Neumeister A Nugent AC Waldeck T Geraci M Schwarz M Bonne O, et al. Neuronal and behavorial responses to tryptophan depletion in unmedicated patients with major depressive disorder and healthy controls Arch Gen Psychiatry 2004; 61: 765-773.
12. Knott VJ Howson AL Perugini M Ravindran AV Young SN. The effect of acute tryptophan depletion and fenfluramine on quantitative EEG and mood in healthy male subjects. Biol Psychiatry 1999; 46: 221-228.
13. Hughes JH Ashton CH Matthews D Young AH. Acute depletion of plasma tryptophan does not alter electrophysiological variables in healthy males. Psychophamacol 2000; 152: 119-121.
14. Phillips M Langley RW Bradshaw CM Szabadi E. The effects of some antidepressant drugs on prepulse inhibition of the acoustic startle (eyeblink) response and the N1/P2 auditory evoked response in man. J Psychopharmacol (2000); 14: 40-45.
15. Young AH Hughes JH Marsh VR Ashton CH. Acute tryptophan depletion attenuates auditory event related potentials in bipolar disorder: A preliminary study. J Affect Disord 2002; 69: 83-92.
16. Bhatti T Gillin JC Seifritz E Moore P Clark C Golshan S, et al. Effects of a tryptophan-free amino acid drink challenge on normal human sleep electroencephalogram and mood. Biol Psychiatry 1998; 43: 52-59.
17. Voderholzer U Hornyak M Thiel B Huwig-Poppe C Kiemen A Konig A, et al. Impact of experimentally induced serotonin deficiency by tryptophan depletion on sleep EEG in healthy subjects. Neuropsychopharmacology 1998; 18: 112-124.
18. Moore P Gillin C Bhatti T De Modena A Seifritz E Clark C, et al. Rapid tryptophan depletion, sleep electroencephalogram, and mood in men with remitted depression on serotonin reuptake inhibitors. Arch Gen Psychiatry 1998; 55: 534-539.
19. Evans L Golshan S Kelsoe J Rapaport M Resovsky K Sutton L Gillin JC. Effects of rapid tryptophan depletion on sleep electroencephalogram and mood in subjects with partially remitted depression on bupropion. Neuropsychopharmacology 2002; 27: 1016-1026.
20. Haynes PL McQuaid JR Kelsoe J Rapaport M Gillin JC. Affective state and EEG sleep profile in response to rapid tryptophan depletion in recently recovered nonmedicated depressed individuals. J Affect Disord 2004; 83: 253-262.
21. Landolt HP Kelsoe JR Rapaport MH Gillin JC. Rapid tryptophan depletion reverses phenelzine-induced suppression of REM sleep. J Sleep Res. 2003; 12: 13-18.
22. Riemann D Feige B Hornyak M Koch S Hohagen F Voderholzer U. The tryptophan depletion test: Impact on sleep in primary insomnia - a pilot study. Psychiatry Res 2002; 109: 129-135.
23. Lewis DA Campbell MJ Foote SL Morrison JH. The monoaminergic innervation of primate neocortex. Hum Neurobiol 1986; 5: 181-188.
24. Jacobs BL Azmitia EC. Structure and function of the brain serotonin system. Physiol Rev 1992; 72: 165-229.
25. Hegerl U Juckel G. Intensity dependence of auditory evoked potentials as an indicator of central serotonergic neurotransmission: A new hypothesis. Biol Psychiatry 1993; 33: 173-187.
26. Ehlers CL Wall TL Chaplin RL. Long latency event-related potentials in rats: Effects of dopaminergic and serotonergic depletions. Pharmacol Biochem Behav 1991; 38: 789-793.
27. von Knorring L Perris C. Biochemistry of the augmenting-reducing response in visual evoked potentials. Neuropsychobiology 1981; 7: 1-8.
28. Pineda JA Holmes TC Foote SL. Intensity-amplitude relationships in monkey event-related potentials: Parallels to human augmenting-reducing responses. Electroencephalogr Clin Neurophysiol 1991; 78: 456-465.
29. Juckel G Hegerl U Molnár M Csépe V Karmos G. Auditory evoked potentials reflect serotonergic neuronal activity - a study in behaving cats administered drugs acting on 5-HT1A autoreceptors in the dorsal raphe nucleus. Neuropsychopharmacology 1999; 21: 710-716.
30. Scherg M Von Cramon D. Two bilateral sources of the late AEP as identified by a spatio-temporal dipole model. Electroencephalogr Clin Neurophysiol 1985; 62: 32-44.
31. Gallinat J Bottlender R Juckel G Munke-Puchner A Stotz G Kuss HJ, et al. The loudness dependency of the auditory evoked N1/P2-component as a predictor of the acute SSRI esponse in depression. Psychopharmacology 2000; 48: 404-411.
32. Wang W Timsit-Berthier M Schoenen J. Intensity dependence of auditory evoked potentials is pronounced in migraine: An indication of cortical potentiation and low serotonergic neurotransmission? Neurology 1996; 46: 1404-1409.
33. Hegerl U Juckel G Schmidt LG Rommelspacher H. Serotonergic ethanol effects and auditory evoked dipole activity in alcoholic and healthy subjects. Psychiatry Res 1996; 63: 47-55.
34. Tuchtenhagen F Daumann J Norra C Gobbele R Becker S Pelz S, et al. High intensity dependence of auditory evoked dipole source activity indicates decreased serotonergic activity in abstinent ecstasy (MDMA) users. Neuropsychopharmacology 2000; 22: 608-671.
35. Juckel G Gallinat J Riedel M Sokullu S Schulz C Moller HJ, et al. Serotonergic dysfunction in schizophrenia assessed by the loudness dependence measure of primary auditory cortex evoked activity. Schizophr Res 2003; 64: 115-124.
36. Norra C Mrazek M Tuchtenhagen F Gobbelé R Buchner H Saβ H Herpertz S. Enhanced intensity dependence as a marker of low serotonergic neurotransmission in borderline personality disorder. J Psychiat Res 2003; 37: 23-33.
37. Buchsbaum M Goodwin F Murphy D Borge G. AER in affective disorders. Am J Psychiatry 1971; 128: 19-25.
38. Paige SR Kirkpatrick DF Kline JP Balogh SE Hendricks SE. Event-related potential amplitude intensity slopes predict response to antidepressants. Neuropsychobiology 1994; 30: 197-201.
39. Pogarell O Juckel G Tatsch K Norra C Müller-Siechender F Mulert C, et al. Auditory evoked potentials and 1231-b-CIT-SPECT as predictors of the differential response to serotonergic versus noradrenergic antidepressants. Pharmacopsychiatry 2003; 36: S253.
40. Juckel G Mavrogiorgou P Bredemaier S Gallinat J Frodl T Schulz C, et al. Loudness dependence of primary auditory-cortex-evoked activity as predictor of therapeutic outcome to prophylactic lithium treatment in affective disorders - a retrospective study. Pharmacopsychiatry 2004; 37: 46-51.
41. Linka T Muller BW Bender S Sartory G. The intensity dependence of the auditory evoked N1 component as a predictor of response to Citalopram treatment in patients with major depression. Neurosci Lett 2004; 367: 375-378.
42. Lee TW Yu YW Chen TJ Tsai SJ. Loudness dependence of the auditory evoked potential and response to antidepressants in Chinese patients with major depression. J Psychiatry Neurosci 2005; 30: 202-205.
43. Dierks T Barta S Demisch L Schmeck K Englert E Kewitz A, et al. Intensity dependence of auditory evoked potentials (AEPs) as biological marker for cerebral serotonin levels: Effects of tryptophan depletion in healthy subjects. Psychopharmacology 1999; 146: 101-107.
44. Phillips M Oxtoby EK Langley RW Bradshaw CM Szabadi E. Effects of acute tryptophan depletion on prepulse inhibition of the acoustic startle (eyeblink) response and the N1/P2 auditory evoked response in man. J Psychopharmacol 2000; 14: 258-265.
45. Massey AE Marsh VR McAllister-Williams RH. Lack of effect of tryptophan depletion on the loudness dependency of auditory event related potentials in healthy volunteers. Biol Psychol 2004; 65: 137-145.
46. Debener S Strobel A Kurschner K Kranzioch C Hebenstreit J Maercker A, et al. Is auditory evoked potential augmentation/reducing affected by acute tryptophan depletion? Biol Psychol 2002; 59: 121-133.
47. Norra C Becker S Broecheler A Vreemann S Kawohl W Sass H Buchner H. Electrophysiological effects of acute tryptophan depletion on human serotonergic functions. Clin EEG Neurosci 2005; 36: 217.
48. McAllister-Williams RH Massey AE Rugg MD. Effects of tryptophan depletion on brain potential correlates of episodic memory retrieval. Psychopharmacology 2002; 160: 434-442.
49. Kahkonen S Jaaskelainen IP Pennanen S Liesivuori J Ahveninen J. Acute tryptophan depletion decreases intensity dependence of auditory evoked magnetic N1/P2 dipole source activity. Psychopharmacology 2002; 164: 221-227.
50. Juckel G Schmidt LG Rommelspacher H Hegerl U. The Tridimensional Personality Questionnaire and the intensity dependence of auditory evoked dipole source activity. Biol Psychiatry 1995; 37: 311-317.
51. Pogarell O Tatsch K Juckel G Hamann C Mulert C Popperl G, et al. Serotonin and dopamine transporter availabilities correlate with the loudness dependence of auditory evoked potentials in patients with obsessive-compulsive disorder. Neuropsychopharmacology 2004; 29: 1910-1917.
52. O'Neill BV Craft RJ Leung S Guille V Galloway M Phan KL Nathan PJ. Dopamine receptor stimulation does not modulate the loudness dependence of the auditory evoked potential in humans. Psychopharmacology 2006; 188: 92-99.
53. Möller O Norra C Gründer G: Monoaminergic function in major depression: A possibly helpful tool for choosing treatment strategy (In German). Nervenarzt 2006; 77: 800-808.
54. Nathan PJ Segrave R Phan KL O'Neill B Croft RJ. Direct evidence that acutely enhancing serotonin with the selective serotonin reuptake inhibitor citalopram modulates the loudness dependence of the auditory evoked potential (LDAEP) marker of central serotonin function. Hum Psychopharmacol 2006; 21: 47-52.
55. Uhl I Gorynia I Gallinat J Mulert C Wutzler A Heinz A Juckel G. Is the loudness dependence of auditory evoked potentials modulated by the selective serotonin reuptake inhibitor citalopram in healthy subjects? Hum Psychopharmacol 2006; 21: 463-471.
56. Kahkonen S Ahveninen J Pennanen S Liesivuori J Llmoniemi RJ Jaaskelainen IP. Serotonin modulates early cortical auditory processing in healthy subjects: Evidence from MEG with acute tryptophan depletion. Neuropsychopharmacology 2002; 27: 862-868.
57. Näätänen R Teder W Alho K Lavikainen J. Auditory attention and selective input modulation: A topographical ERP study. Neuroreport 1992; 3: 493-496.
58. Ahveninen J Kahkonen S Pennanen S Liesivuori J Llmoniemi RJ Jaaskelainen IP. Tryptophan depletion effects on EEG and MEG responses suggest serotonergic modulation of auditory involuntary attention in humans. Neuroimage 2002; 16: 1052-1061.
59. Kahkonen S Makinen V Jaaskelainen IP Pennanen S Liesivuori J Ahveninen J. Serotonergic modulation of mismatch negativity. Psychiatry Res 2005; 138: 61-74.
60. Ahveninen J Jaaskelainen IP Pennanen S Liesivuori J Llmoniemi RJ Kahkonen S. Auditory selective attention modulated by tryptophan depletion in humans. Neurosci Let 2003; 340: 181-184.
61. Koch M. The neurobiology of startle. Progress Neurobiol 1999; 59: 107-128.
62. Geyer MA Krebs-Thomson K Braff DL Swerdlow NR. Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: A decade in review. Psychopharmacology 2001; 156: 117-154.
63. Sipes TA Geyer MA. Multiple serotonin subtypes modulate prepulse inhibition of the startle response in rats. Neuropharmacology 1994; 33: 441-448.
64. Fletcher PJ Selhi ZF Azampanah A Sills TL. Reduced brain serotonin activity disrupts prepulse inhibition of the acoustic startle reflex: Effects of 5,7-dihydroxytryptamine and p-chlorophenylalanine. Neuropsychopharmacology 2001; 24: 399-409.
65. Kehne JH Padich RA McCloskey TC Taylor VL Schmidt CJ. 5-HT modulation of auditory and visual sensorimotor gating: I. Effects of 5-HT releasers on sound and light prepulse inhibition in Wistar rats. Psychopharmacology 1996; 124: 95-106.
66. Walters JK Davis M Sheard MH. Tryptophan-free diet: Effects on the acoustic startle reflex in rats. Psychopharmacology 1979; 62: 103-109.
67. Norra C Becker S Brocheler A Vreemann S Herpertz S Sass H. Acoustic startle modulation by acute tryptophan depletion in healthy females. Int J Neuropsychopharmacol 2002; 5: S194.
68. Gouzoulis-Mayfrank E Heekeren K Thelen B Lindenblatt H Kovar KA Sass H Geyer MA. The hallucinogen psilocybin increases prepulse inhibition of the startle reflex in the healthy humans. Behav Pharmacol 1998; 9: 561-566.
69. Vollenweider FX Remensberger S Hell D Geyer MA. Opposite effects of 3,4-methylenedioxymethamphetamine (MDMA) on sensorimotor gating in rats versus healthy humans. Psychopharmacology 1999; 143: 365-372.
70. Liechti ME Geyer MA Hell D Vollenweider FX. Effects of MDMA (Ecstasy) on prepulse inhibition and habituation of startle after pretreatment with citalopram, haloperidol, or ketanserin. Neuropsychopharmacology 2001; 24: 240-252.
71. Quednow BB Kühn K-U Stelzenmueller R Hoenig K Maier W Wagner M. Effects of serotonergic and noradrenergic antidepressants on auditory startle response in patients with major depression. Psychopharmacology 2004; 175: 399-405.
72. Sjoerdsma A Engelman K Spector S. Inhibition of catecholamine synthesis in man with a-methyl-paratyrosine, an inhibitor of tyrosine hydroxylase. Lancet 1965; 2: 1092-1094.
73. Bremner JD Vythilingam M Ng CK Vermetten E Nazeer A Oren DA, et al. Regional brain metabolic correlates of alpha-methylparatyrosine-induced depressive symptoms: Implications for the neural circuitry of depression. JAMA 2003; 289: 3125-3134.
74. Delgado PL Moreno FA Onate L Gelenberg AJ. Sequential catecholamine and serotonin depletion in mirtazapine-treated depressed patients. Int J Neuropsychopharmacol 2002; 5: 63-66.
75. Neumeister A Turner EH Matthews JR Postolache TT Barnett RL Rauh M, et al. Effects of tryptophan depletion vs. catecholamine depletion in patients with seasonal affective disorder in remission with light therapy. Arch Gen Psychiatry 1998; 55: 524-530.
76. Anand A Darnell A Miller HL Berman RM Cappiello A Oren DA, et al. Effect of catecholamine depletion on lithium-induced long-term remission of bipolar disorder. Biol Psychiatry 1999; 45: 972-978.
77. Voruganti L Slomka P Zabel P Costa G So A Mattar A Awad A.G., Subjective effects of AMPT-induced dopamine depletion in schizophrenia: Correlation between dysphoric responses and striatal D(2) binding ratios on SPECT imaging. Neuropsychopharmacology. 2001; 25: 642-650.
78. Leppavuori A. The effects of an alpha-adrenergic agonist or antagonist on sleep during blockade of catecholamine synthesis in the cat. Brain Res 1980; 193: 117-128.
79. Rondouin G Baldy-Moulinier M Passouant P. The influence of hippocampal kindling on sleep organization in cats: Effects of alpha-methylparatyrosine. Brain Res 1980; 181: 413-424.
80. McCann UD Thorne D Hall M Popp K Avery W Sing H, et al. The effects of L-dihydroxyphenylalanine on alertness and mood in alpha-methyl-para-tyrosine-treated healthy humans. Neuropsychopharmacology 1995; 13: 41-52.
81. Salomon RM Miller HL Krystal JH Henninger GR Charney DS. Lack of behavioral effects of monoamine depletion in healthy subjects. Biol Psychiatry 1997; 41: 58-64.
82. Biggio G Porceddu ML Gessa GL. Decrease of homovanillic, dihydroxyphenylacetic acid and cyclic-adenosine-30, 50-monophosphate content in the rat caudate nucleus induced by the acute administration of an aminoacid mixture lacking tyrosine and phenylalanine. J Neurochem 1976; 26: 1253-1255.
83. Montgomery AJ McTavish SF Cowen PJ Grasby PM. Reduction of brain dopamine concentration with dietary tyrosine plus phenylalanine depletion: An [11C]raclopride PET study. Am J Psychiatry 2003; 160: 1887-1889.
84. Leyton M Dagher A Boileau I Casey K Baker GB Diksic M, et al. Decreasing amphetamine-induced dopamine release by acute phenylalanine /tyrosine depletion: A PET/[11C]raclo-pride study in healthy men. Neuropsychopharmacology 2004; 29: 427-432.
85. Leyton M Young SN Blier P Baker GB Pihl RO Benkelfat C. A comparison of the effects of acute tryptophan depletion and acute phenylalanine/tyrosine depletion in healthy women. Adv Exp Med Biol 1999; 46: 767-771.
86. Harrison BJ Olver JS Norman TR Nathan PJ. Effects of serotonin and catecholamine depletion on interleukin-6 activation and mood in human volunteers. Hum Neuropsychopharmacol 2002; 17: 293-297.
87. Roiser JP McLean A Ogilvie AD Blackwell AD Bamber DJ Goodyer I, et al. The subjective and cognitive effects of acute phenylalanine and tyrosine depletion in patients recovered from depression. Neuropsychopharmacology 2005; 30: 775-785.
88. Healy D McMonagle T. The enhancement of social functioning as atherapeutic principle in the management of depression. J. Psychopharmacol 1997; 11(4 suppl): S25-31.